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Is There a Relationship between Hyperkalemia and 
Propofol? 
This is a case of a sudden cardio-pulmonary arrest in a 29 year-old female, 
which occurred immediately after a large bolus infusion of propofol (100 mg) 
intravenously during dilatation and curettage. The arrest suddenly occurred, 
and the patient was eventually transferred to our emergency room (ER) on 
cardiopulmonary resuscitation. At that time, severe hyperkalemia up to 9.1 mEq/
L and ventricular fibrillation were noted. Resuscitation in ER worked successfully 
with conversion of electrocardiograph to sinus rhythm, but this patient expired 
unfortunately. On view of this acute event immediately after the bolus injection 
of propofol accompanied without other identified causes, severe hyperkalemia 
induced by propofol was strongly assumed to be the cause of death. To our 
understanding with the literature survey, propofol as a cause of hyperkalemia 
has not been well described yet. Through this case, the relationship as a cause 
and an effect between propofol and hyperkalemia is suggested. 
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PRIS is assumed to be related with disruption of fatty acid 
oxidation and failure of the mitochondrial respiratory 
chain
3, 6, 7).
The development of hyperkalemia has been reported 
in patients after propofol infusion anaesthesia
6, 8-10), 
suggesting that hyperkalemia could be associated with 
propofol infusion. However, there is no case report of 
sudden cardiopulmonary arrest immediately after propofol 
infusion accompanied by severe hyperkalemia. In addition, 
the relationship between propofol and hyperkalemia is not 
clarified yet. Hereby, we report a case in which propofol 
was assumed to cause severe hyperkalemia leading to death, 
and propose the relationship between propofol itself and 
the development of hyperkalemia. 
Introduction
Propofol is widely used in anesthesia at intensive care 
units and out-patients-unit procedures due to its short term 
sedation effects and safe pharmacodynamics. However, 
propofol infusion syndrome (PRIS) was suspected in 
pediatric patients in the 1990s
1) and then Bray et al.
2) 
introduced the term first in 1998. After that, PRIS was also 
observed in adult patients
3). PRIS is a rare, but frequently 
fatal complication of prolonged propofol infusion at 
high doses. This syndrome is characterized by metabolic 
acidosis, arrhythmias, myocardial failure, rhabdomyolysis, 
hyperkalemia, renal failure, fatty degeneration of liver, and 
then eventually causes death in some cases
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Case report
A 29-year-old female was transferred to our emergency 
room (ER), in cardiopulmonary arrest state which occurred 
during dilatation and curettage at a local obstetric unit. The 
dilatation and curettage were performed due to intrauterine 
fetal death at 24 weeks of gestation. During the procedure, 
bolus injection of propofol (100 mg in 10 mL) was used for 
sleep induction. Electrocardiography (EKG) showed sinus 
rhythm before the propofol was injected. Approximately 
10 seconds after its injection, cyanosis appeared on the lips 
with oxygen saturation falling to 40%. Consequently, the 
arrest occurred, and intubation with cardiopulmonary 
resuscitation (CPR) was performed. Then, the patient was 
transferred to the ER, at Hanyang University Guri Hospital, 
with continuation of CPR. Forty minutes passed before her 
arrival to the ER, but asystole was still present in the ER. 
Crackle sound was heard from both lungs and pulmonary 
edema was noted on the chest X-ray. 
The hematological study showed white cells at 21 × 10
3/
μL, hemoglobin 10.4 g/dL, hematocrit 31.7%, and platelets 
238 × 10
3/μL. The serum electrolytes showed a sodium 
level of 128 mEq, potassium 9.1 mEq/L, and chloride 97 
mEq/L with blood chemistry of creatinine at 0.6 mg/dL, 
urea nitrogen 11 mg/dl, bilirubin 0.6 mg/dL, aspartate 
aminotrasferase 1,088 U/L, alanine aminotransferase 548 
U/L, total protein 6.2 g/dL, albumin 2.8 g/dL, alkaline 
phosphatase 966 U/L, lactate dehydrogenase 9,135 U/L, 
creatine kinase 1,146 U/L, calcium 9.7 mg/dL, phosphorus 
13.1 mg/dL, creatine kinase isoenzymes 125 ng/mL, 
myoglobulin 1,451 ng/mL, troponin-I 18.38 ng/mL, 
glucose 340 mg/dL, and osmolality 305 mOsm/kg. The 
Fig. 1. A) Ventricular fibrillation developed during resuscitation in the emergency room (ER). 
B) and C) After defibrillation and emergent treatments of hyperkalemia, tall T waves with 
atrial fibrillation and then regular sinus rhythm followed.Electrolyte Blood Press 9:27-31, 2011 • doi: 10.5049/EBP.2011.9.1.27    29
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blood gas revealed pH of 6.99, PCO2 52.7 mmHg, PO2 
90.7 mmHg, bicarbonate 13.0 mEq/L, base-excess –17.6, 
and O2 saturation 90%. 
To control hyperkalemia, 10% calcium gluconate and 
10 units insulin mixed with 50 mL of 50% glucose fluid 
were infused, and after 10 minutes, the patient seemed 
to be resuscitated. However, 6 minutes later, ventricular 
fibrillation occurred and defibrillation was conducted 
immediately. Before the conversion to sinus rhythm was 
accomplished consequently, symmetric tall T waves with 
atrial fibrillation followed temporarily (Fig. 1). Then, blood 
pressure and pulse rate were maintained at 109/47 mmHg 
and 68 per minute, respectively, with inotropics. Stuporous 
mental status and complete anuria was noted despite 
intravenous furosemide injection up to 160 mg in total but 
the repeat levels of serum creatinine and potassium in the 
ER were 0.9 mg/dL and 7.7 mEq/L, respectively. Her family 
members refused further management in our intensive care 
unit. She was moved to a local medical unit near her home 
and expired there within 1 day.
Discussion
A healthy 29-year-old female in pregnancy developed 
cardiopulmonary arrest while receiving dilatation and 
curettage, right after propofol was injected. In spite of the 
CPR, resuscitation wasn’t successful until the management 
of hyperkalemia was initiated. In this case, there could be 
much debate on the causes of the arrest, such as respiratory 
failure with airway problem, amniotic fluid embolism, 
anaphylaxis, and PRIS. As common accidents of other 
sedatives, airway problem would be suspected first, but 
the interval between injection and arrest was too short 
(about 10 seconds) to explain that hypoxia alone caused 
the cardiopulmonary arrest. As intubation was performed 
immediately, even if it was due to the respiratory failure, the 
patient should have been resuscitated after oxygen supply. 
Amniotic fluid embolism could occur during dilatation 
and curettage. But as described in the case reported by Ray 
et al.
11), blood potassium level did not rise typically and 
usually recovered after CPR. In addition, typical features 
of disseminated intravascular coagulation (DIC) including 
thrombocytopenia weren’t seen in this patient. Also, among 
the usual cases of anaphylaxis, they did not develop severe 
hyperkalemia and ventricular fibrillation right after its 
development. Furthermore, Castillo et al. described that 
propofol under 2 mg/kg should be safe in local anesthesia of 
delivery
12). 
PRIS is one of the well known side effects of propofol as 
mentioned above. The present case is somewhat different 
from previously reported PRIS cases. PRIS usually occurs 
when propofol is used in doses of more than 4 mg/kg/
hr for more than 48hours
6). On the contrary, in this 
case, cardiopulmonary arrest occurred directly after an 
intravenous bolus injection of propofol. So far, 71 PRIS 
cases are reported. But none of them occurred right after 
the injection of propofol. The shortest onset time of PRIS 
was at least 40 minutes
6, 9). Among 61 cases of PRIS
6) 
reviewed by Kam and Cardone, hyperkalemia was only 
noted in 8 cases out of a total of 38 expired ones, but none 
in survived cases. In a case of PRIS reported by Strikland 
and Murray, metabolic acidosis and hyperkalemia occurred 
after continuous infusion of the propofol, but hyperkalemia 
was aggravated causing death in spite of improvement of 
metabolic acidosis by bicarbonate infusion
13). On the other 
hand, Vernooy et al.
10) reported that 3 of the 7 PRIS patients 
and 6 of the 60 non-PRIS patients had hyperkalemia, 
among a total of 67 patients who received long term 
propofol. These indicate that propofol could develop 
hyperkalemia regardless of the clinical status either with or 
without PRIS. 
Since there was no evidence of DIC, no significant 
elevation of muscle enzymes, and within normal range 
of serum creatinine, it is hard to suggest that hemolysis, 
muscle cell destruction or acute renal failure induced se-
vere hyperkalemia up to a level of 9.1 mEq/L as in this 
case. After emergent attempts were conducted for severe 
hyperkalemia including calcium gluconate, and insulin with 
glucose, the patient was resuscitated. Notably, ventricular 
fibrillation had changed to atrial fibrillation with symmetric 30      JH Lee et al. • Is There a Relationship between Hyperkalemia and Propofol? 
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tall T waves, and then to sinus rhythm with normal T waves 
after severe hyperkalemia was managed with emergent 
remedies. This evidence suggests that the immediate cardio-
pulmonary arrest could have been caused by hyperkalemia, 
of which cause is related to the propofol.
Succinylcholine has been known to cause hyperkalemia 
by diffusion of potassium during prolonged muscle 
depolarization
14). In an interesting case reported by 
Piotrowski et al.
15), hyperkalemia and cardiac arrest 
occurred in a patient immediately after anesthesia using 
both succinylcholine and propofol. However, no side effect 
was observed after initial succinylcholine administration 
in this patient. It could be possible that the cardiac arrest 
and hyperkalemia were induced by propofol rather than 
succinylcholine. Another similar case showed hyperkalemia 
and polymorphic ventricular tachycardia, which occurred 
during resuscitation on the arrest developed right after 
injection of propofol and succinylcholine
16). 
The main mechanism of PRIS could be explained 
through the disturbance of the mitochondrial fatty acid 
metabolism. The mechanism of PRIS could be similar 
to mitochondrial myopathy, in which there are specific 
defects in the mitochondrial respiratory chain
3). A case of 
hyperkalemia with severe metabolic acidosis in an infant 
with mitochondrial fatty acid oxidation disorder, suggests 
that potassium homeostasis could have a relationship with 
mitochondrial metabolism
17). Meanwhile, propofol could 
develop lactic acidemia through the impairment of free fatty 
acid utilization and mitochondrial activity in muscles and 
heart
18). In a recent report, compared to another anesthetic 
agent, propofol has shown significant effects that produce 
lactic acidosis
18). However, as hyperkalemia does not occur 
in organic metabolic acidosis
14), hyperkalemia of propofol 
would not have any correlations with lactic acidosis.
Despite the lack of clarified mechanisms that explain 
how propofol could influence potassium homeostasis, 
there is a possible suggestion of a proven effect of propofol 
in an animal study. Zhou et al. found that propofol could 
decrease beta-adrenoceptor responsiveness to isoproterenol 
in rats
19) which may imply that propofol could have effects 
to block the intracellular potassium shift of beta-agonists. 
Severe acute hyperphosphatemia, which was probably 
the result of extracellular shift of phosphate along with 
potassium without the influence of tumor lysis syndrome 
or significant rhabdomyolysis, may be another indicator 
that the cause of hyperkalemia was transcellular movement 
rather than that of other mechanisms. In fact, transcellular 
movement of potassium is usually accompanied by the 
same directional movement of phosphate with insulin or 
change of pH and even in thyrotoxic periodic paralysis
20). 
Derangement of internal balance of potassium homeostasis, 
transcellular shift of potassium is strongly suggested as this 
cause of acute onset hyperkalemia rather than derangement 
of external balance of potassium in this patient, although 
urinary biochemical indices such as transtubular potassium 
gradient (TTKG) were not taken.
In the body, most of the potassium is contained in muscle 
and liver. PRIS usually associates with rhabdomyolysis, 
so the occurrence of hyperkalemia could be secondary by 
rhabdomyolysis. In some reports, however, hyperkalemia 
occurred without rhabdomyolysis. In the review of Kam 
and Cardone, 5 out of 11 patients had hyperkalemia 
without rhabdomyolysis
6). In the report of Vernooy et al., 6 
out of 60 non-PRIS patients had hyperkalemia
10). Moreover, 
the patient’s CPK level was just 1,146 U/L, not so high for 
significant rhabdomyolysis. 
In conclusion, considering all of the clinical clues and a 
review of the data from the previous reports of humans 
and animal experiments about propofol, there may be 
a close relationship between the development of severe 
hyperkalemia and propofol in this report. However, 
there still remains lack of evidence that could explain 
the exact pathophysiology of hyperkalemia following 
propofol injection, despite various speculation including 
depressed beta adrenoceptor-agonist effect and transcelluar 
movement of potassium along with phosphate.
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